BIOMARIN PHARMACEUTICAL INC Foreign Currency Transaction Gain (Loss), Unrealized
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Foreign Currency Transaction Gain (Loss), Unrealized of $4.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC foreign currency transaction gain (loss), unrealized for the quarter ending 2026-06-30 was $10.76M.
- BIOMARIN PHARMACEUTICAL INC foreign currency transaction gain (loss), unrealized for the quarter ending 2026-03-31 was -$6.71M, a 166.93% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC foreign currency transaction gain (loss), unrealized for the quarter ending 2025-12-31 was -$4.21M.
- BIOMARIN PHARMACEUTICAL INC foreign currency transaction gain (loss), unrealized for the quarter ending 2025-09-30 was -$5.55M, a 331.83% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC foreign currency transaction gain (loss), unrealized for fiscal 2025 was -$4.46M, a 126.62% decline from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC foreign currency transaction gain (loss), unrealized for fiscal 2024 was $16.75M.
- BIOMARIN PHARMACEUTICAL INC foreign currency transaction gain (loss), unrealized for fiscal 2023 was -$28.45M, a 299.10% decline from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC foreign currency transaction gain (loss), unrealized for fiscal 2022 was $14.29M, a 689.34% increase from fiscal 2021.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.05M 10-Q · filed 2026-08-06 | -$169.00K derived: sum of 3 quarters · filed 2026-08-06 | -$5.72M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$6.71M 10-Q · filed 2026-05-05 | -$10.93M derived: sum of 2 quarters · filed 2026-05-05 | -$16.48M derived: sum of 3 quarters · filed 2026-05-05 | -$21.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$4.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$9.77M derived: sum of 2 quarters · filed 2026-02-26 | -$14.48M derived: sum of 3 quarters · filed 2026-08-06 | -$4.46M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$5.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$10.27M derived: sum of 2 quarters · filed 2026-08-06 | -$244.00K 10-Q · filed 2025-10-28 | -$5.84M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$4.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $5.31M 10-Q · filed 2026-08-06 | -$293.00K derived: sum of 3 quarters · filed 2026-08-06 | $2.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $10.03M 10-Q · filed 2026-05-05 | $4.43M derived: sum of 2 quarters · filed 2026-05-05 | $6.82M derived: sum of 3 quarters · filed 2026-05-05 | $15.97M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.21M derived: sum of 2 quarters · filed 2026-02-26 | $5.95M derived: sum of 3 quarters · filed 2026-02-26 | $16.75M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $11.55M derived: sum of 2 quarters · filed 2025-10-28 | $22.35M 10-Q · filed 2025-10-28 | -$640.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $9.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $19.96M 10-Q · filed 2025-08-05 | -$3.03M derived: sum of 3 quarters · filed 2026-02-26 | -$1.03M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $10.80M 10-Q · filed 2025-05-02 | -$12.19M derived: sum of 2 quarters · filed 2026-02-26 | -$10.19M derived: sum of 3 quarters · filed 2026-02-26 | -$11.03M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$22.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$20.99M derived: sum of 2 quarters · filed 2026-02-26 | -$21.83M derived: sum of 3 quarters · filed 2026-02-26 | -$28.45M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $1.16M derived: sum of 2 quarters · filed 2024-10-31 | -$5.45M 10-Q · filed 2024-10-31 | -$7.24M derived: sum of 4 quarters · filed 2025-02-24 |
| 2023-06-30 | -$840.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$7.46M 10-Q · filed 2024-08-05 | -$9.24M derived: sum of 3 quarters · filed 2025-02-24 | -$5.50M derived: sum of 4 quarters · filed 2025-02-24 |
| 2023-03-31 | -$6.62M 10-Q · filed 2024-04-26 | -$8.40M derived: sum of 2 quarters · filed 2025-02-24 | -$4.66M derived: sum of 3 quarters · filed 2025-02-24 | $785.00K derived: sum of 4 quarters · filed 2025-02-24 |
| 2022-12-31 | -$1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $1.95M derived: sum of 2 quarters · filed 2025-02-24 | $7.40M derived: sum of 3 quarters · filed 2025-02-24 | $14.29M 10-K · filed 2025-02-24 |
| 2022-09-30 | $3.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $9.19M derived: sum of 2 quarters · filed 2023-11-02 | $16.07M 10-Q · filed 2023-11-02 | $16.54M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $5.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $12.33M 10-Q · filed 2023-08-02 | $12.80M derived: sum of 3 quarters · filed 2024-02-26 | $13.14M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $6.89M 10-Q · filed 2023-04-28 | $7.35M derived: sum of 2 quarters · filed 2024-02-26 | $7.69M derived: sum of 3 quarters · filed 2024-02-26 | $12.65M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $463.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $806.00K derived: sum of 2 quarters · filed 2024-02-26 | $5.76M derived: sum of 3 quarters · filed 2024-02-26 | $1.81M 10-K · filed 2024-02-26 |
| 2021-09-30 | $343.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $5.30M derived: sum of 2 quarters · filed 2022-10-28 | $1.35M 10-Q · filed 2022-10-28 | $2.42M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $4.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.00M 10-Q · filed 2022-08-04 | $2.08M derived: sum of 3 quarters · filed 2023-02-27 | -$4.81M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | -$3.95M 10-Q · filed 2022-04-29 | -$2.88M derived: sum of 2 quarters · filed 2023-02-27 | -$9.76M derived: sum of 3 quarters · filed 2023-02-27 | -$2.56M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$5.81M derived: sum of 2 quarters · filed 2023-02-27 | $1.39M derived: sum of 3 quarters · filed 2023-02-27 | -$8.01M 10-K · filed 2023-02-27 |
| 2020-09-30 | -$6.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $318.00K derived: sum of 2 quarters · filed 2021-10-29 | -$9.08M 10-Q · filed 2021-10-29 | -$9.32M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $7.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$2.20M 10-Q · filed 2021-07-30 | -$2.44M derived: sum of 3 quarters · filed 2022-02-25 | -$2.43M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | -$9.40M 10-Q · filed 2021-04-30 | -$9.64M derived: sum of 2 quarters · filed 2022-02-25 | -$9.63M derived: sum of 3 quarters · filed 2022-02-25 | -$10.84M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | -$241.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$226.00K derived: sum of 2 quarters · filed 2022-02-25 | -$1.44M derived: sum of 3 quarters · filed 2022-02-25 | -$1.02M 10-K · filed 2022-02-25 |
| 2019-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$1.20M derived: sum of 2 quarters · filed 2020-11-06 | -$784.00K 10-Q · filed 2020-11-06 | $4.99M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$799.00K 10-Q · filed 2020-08-05 | $4.97M derived: sum of 3 quarters · filed 2021-02-26 | $11.27M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $419.00K 10-Q · filed 2020-05-01 | $6.19M derived: sum of 2 quarters · filed 2021-02-26 | $12.49M derived: sum of 3 quarters · filed 2021-02-26 | $23.80M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $5.77M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | $12.07M derived: sum of 2 quarters · filed 2021-02-26 | $23.38M derived: sum of 3 quarters · filed 2021-02-26 | $17.77M 10-K · filed 2021-02-26 |
| 2018-09-30 | $6.30M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2019-11-04 | $17.61M derived: sum of 2 quarters · filed 2019-11-04 | $12.00M 10-Q/A · filed 2019-11-04 | $10.09M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $11.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $5.69M 10-Q · filed 2019-08-02 | $3.78M derived: sum of 3 quarters · filed 2020-02-27 | -$5.43M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$5.62M 10-Q · filed 2019-04-29 | -$7.53M derived: sum of 2 quarters · filed 2020-02-27 | -$16.74M derived: sum of 3 quarters · filed 2020-02-27 | -$13.60M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$11.13M derived: sum of 2 quarters · filed 2020-02-27 | -$7.99M derived: sum of 3 quarters · filed 2020-02-27 | -$6.26M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$9.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | -$6.08M derived: sum of 2 quarters · filed 2018-10-26 | -$4.35M 10-Q · filed 2018-10-26 | -$828.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $3.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $4.87M 10-Q · filed 2018-08-03 | $8.39M derived: sum of 3 quarters · filed 2019-02-28 | $11.47M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $1.73M 10-Q · filed 2018-04-27 | $5.25M derived: sum of 2 quarters · filed 2019-02-28 | $8.33M derived: sum of 3 quarters · filed 2019-02-28 | $9.69M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $6.60M derived: sum of 2 quarters · filed 2019-02-28 | $7.96M derived: sum of 3 quarters · filed 2019-02-28 | $14.48M 10-K · filed 2019-02-28 |
| 2016-09-30 | $3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $4.43M derived: sum of 2 quarters · filed 2017-10-31 | $10.96M 10-Q · filed 2017-10-31 | $14.04M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $7.88M 10-Q · filed 2017-08-02 | $10.97M derived: sum of 3 quarters · filed 2018-02-26 | $17.25M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $6.53M 10-Q · filed 2017-05-04 | $9.61M derived: sum of 2 quarters · filed 2018-02-26 | $15.90M derived: sum of 3 quarters · filed 2018-02-26 | $20.41M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $9.37M derived: sum of 2 quarters · filed 2018-02-26 | $13.89M derived: sum of 3 quarters · filed 2018-02-26 | $19.57M 10-K · filed 2018-02-26 |
| 2015-09-30 | $6.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $10.80M derived: sum of 2 quarters · filed 2016-11-03 | $16.49M 10-Q · filed 2016-11-03 | $19.68M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $4.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $10.20M 10-Q · filed 2016-08-08 | $13.39M derived: sum of 3 quarters · filed 2017-02-27 | $13.64M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $5.69M 10-Q · filed 2016-05-02 | $8.87M derived: sum of 2 quarters · filed 2017-02-27 | $9.12M derived: sum of 3 quarters · filed 2017-02-27 | $7.84M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $3.44M derived: sum of 2 quarters · filed 2017-02-27 | $2.15M derived: sum of 3 quarters · filed 2017-02-27 | $832.00K 10-K · filed 2017-02-27 |
| 2014-09-30 | $252.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | -$1.03M derived: sum of 2 quarters · filed 2015-11-02 | -$2.35M 10-Q · filed 2015-11-02 | -$3.39M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$2.61M 10-Q · filed 2015-08-05 | -$3.64M derived: sum of 3 quarters · filed 2016-02-29 | -$3.35M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$1.32M 10-Q · filed 2015-05-05 | -$2.36M derived: sum of 2 quarters · filed 2016-02-29 | -$2.06M derived: sum of 3 quarters · filed 2016-02-29 | -$1.03M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$739.00K derived: sum of 2 quarters · filed 2016-02-29 | $294.00K derived: sum of 3 quarters · filed 2016-02-29 | $658.00K 10-K · filed 2016-02-29 |
| 2013-09-30 | $295.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | $1.33M derived: sum of 2 quarters · filed 2014-10-28 | $1.69M 10-Q · filed 2014-10-28 | $3.38M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $1.40M 10-Q · filed 2014-07-31 | $3.08M derived: sum of 3 quarters · filed 2015-03-02 | $5.59M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $364.00K 10-Q · filed 2014-05-02 | $2.05M derived: sum of 2 quarters · filed 2015-03-02 | $4.55M derived: sum of 3 quarters · filed 2015-03-02 | $5.01M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $4.19M derived: sum of 2 quarters · filed 2015-03-02 | $4.65M derived: sum of 3 quarters · filed 2015-03-02 | $6.53M 10-K · filed 2015-03-02 |
| 2012-09-30 | $2.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $2.97M derived: sum of 2 quarters · filed 2013-10-28 | $4.85M 10-Q · filed 2013-10-28 | $3.37M derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-06-30 | $462.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $2.34M 10-Q · filed 2013-07-29 | $865.00K derived: sum of 3 quarters · filed 2014-02-26 | -$2.72M derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-03-31 | $1.88M 10-Q · filed 2013-04-29 | $403.00K derived: sum of 2 quarters · filed 2014-02-26 | -$3.18M derived: sum of 3 quarters · filed 2014-02-26 | -$5.70M derived: sum of 4 quarters · filed 2014-02-26 |
| 2011-12-31 | -$1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | -$5.06M derived: sum of 2 quarters · filed 2014-02-26 | -$7.58M derived: sum of 3 quarters · filed 2014-02-26 | -$7.17M 10-K · filed 2014-02-26 |
| 2011-09-30 | -$3.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | -$6.10M derived: sum of 2 quarters · filed 2012-10-29 | -$5.70M 10-Q · filed 2012-10-29 | -$5.15M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | -$2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$2.12M 10-Q · filed 2012-08-02 | -$1.57M derived: sum of 3 quarters · filed 2013-02-26 | $628.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | $401.00K 10-Q · filed 2012-04-30 | $952.00K derived: sum of 2 quarters · filed 2013-02-26 | $3.15M derived: sum of 3 quarters · filed 2013-02-26 | $4.56M derived: sum of 4 quarters · filed 2013-02-26 |
| 2010-12-31 | $551.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $2.75M derived: sum of 2 quarters · filed 2013-02-26 | $4.16M derived: sum of 3 quarters · filed 2013-02-26 | $4.22M 10-K · filed 2013-02-26 |
| 2010-09-30 | $2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $3.61M derived: sum of 2 quarters · filed 2011-10-31 | $3.67M 10-Q · filed 2011-10-31 | $7.39M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $1.48M 10-Q · filed 2011-08-01 | $5.20M derived: sum of 3 quarters · filed 2012-02-22 | $4.20M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-03-31 | $60.00K 10-Q · filed 2011-04-29 | $3.79M derived: sum of 2 quarters · filed 2012-02-22 | $2.78M derived: sum of 3 quarters · filed 2012-02-22 | |
| 2009-12-31 | $3.73M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $2.72M derived: sum of 2 quarters · filed 2012-02-22 | -$602.00K 10-K · filed 2012-02-22 | |
| 2009-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | -$4.33M 10-Q · filed 2010-10-29 | ||
| 2009-06-30 | -$3.32M 10-Q · filed 2010-08-04 | |||
| 2008-12-31 | $228.00K 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |